Came to Endpoints after some globetrotting years as a journalist and teacher. He's interested in the emerging fields of gene therapy and psychedelic research. A graduate of Northwestern University, he previously worked for Bloomberg BNA, the Weekend Argus in Cape Town and the Chautauquan Daily. Outside of biopharma, he loves dogs (especially labradors), the writer Charles D'Ambrosio, and the New York Mets.